Most work in the cervical cancer field has focused on candidate genes that were identified by gene expression profiling in cervical cancer cell lines and ... cervical cancer. Table 2 lists ...

This modification did not diminished the neutralizing capacity of convalescent sera, but it increased the efficiency of S-induced cell-cell fusion. These findings highlight the mutation’s ... Calu-3 ...

unresectable non-small cell lung cancer (NSCLC) whose tumours have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations and whose disease has not ...

Recent advances in spatial omics technologies have enabled new approaches for analyzing tissue morphology, cell composition, and biomolecule expression patterns in situ. These advances are promoting ...

Scientists identified early genetic mutations in healthy women’s breast cells that may lead to breast cancer, particularly in ...

Researchers have pinpointed what could be the early genetic origins of breast cancer -- cancer-like mutations appearing ... detected in the luminal cells that line the lobules and ducts where ...

Metastasis is responsible for 90 percent of cancer deaths. Researchers have found that the mutations driving it may stem from a commonly inherited variant of the PCSK9 gene.

A mathematical model shows that mutations that recur even modestly among cancer patients are cancer driving nucleotides that can be exhaustively identified to serve as targets of cancer therapy.

Analyses of discovered cancer-driving nucleotides (CDNs) reveal their evolutionary, biochemical, and therapeutic characteristics that are often shared among multiple cancer types.

"It's striking to see cancer-like mutations happening silently and ... they were only detected in the luminal cells that line the lobules and ducts where milk flows through the breast, and not ...